Related Experiment Video
Updated: Aug 29, 2026

Reconstitution Of β-catenin Degradation In Xenopus Egg Extract
Published on: June 17, 2014
Targeted degradation of beta-catenin by chimeric F-box fusion proteins
Jun Liu1, Jeffery Stevens, Nori Matsunami
1Ernest Gallo Clinic and Research Center, University of California San Francisco, Emeryville, CA 94608, USA.
Abstract:
Adenomatous polyposis coli (APC) tumor suppressor protein, together with Axin and glycogen synthase kinase 3beta (GSK-3beta), forms a Wnt-regulated signaling complex that mediates phosphorylation-dependent degradation of cytoplasmic beta-catenin by ubiquitin-dependent proteolysis. Degradation of phosphorylated beta-catenin is initiated by interaction through the WD40-repeat of a F-box protein beta-TrCP, a component of SCF ubiquitin ligase complex. Mutations in APC, Axin, and beta-catenin that prevent down-regulation of cytoplasmic beta-catenin are found in various types of cancers. In the search for efficient treatment and prevention of malignancies associated with increased levels of cytoplasmic beta-catenin, we created chimeric F-box fusion proteins by replacing the WD40-repeat of beta-TrCP with the beta-catenin-binding domains of Tcf4 and E-cadherin. Expression of chimeric F-box fusion proteins successfully promotes degradation of beta-catenin independently of GSK-3beta-mediated phosphorylation. More importantly, this degradation does not require intact APC protein (pAPC).
Insights
Researchers developed novel fusion proteins to degrade beta-catenin, a protein linked to cancer. This approach bypasses the need for Adenomatous polyposis coli (APC) protein and GSK-3beta, offering a new avenue for cancer treatment.
Area of Science:
- Molecular Biology
- Cellular Biology
- Cancer Research
Background:
- The Wnt signaling pathway regulates beta-catenin levels, crucial for cell growth and differentiation.
- Aberrant beta-catenin accumulation, often due to mutations in APC or beta-catenin itself, drives various cancers.
- The SCF(beta-TrCP) ubiquitin ligase complex targets phosphorylated beta-catenin for degradation.
Purpose of the Study:
- To develop a novel therapeutic strategy for cancers characterized by elevated beta-catenin.
- To create chimeric F-box proteins capable of targeting beta-catenin for degradation independently of canonical Wnt pathway components.
Main Methods:
- Constructed chimeric F-box fusion proteins by substituting the beta-TrCP WD40-repeat with beta-catenin-binding domains from Tcf4 and E-cadherin.
- Assessed the efficacy of these fusion proteins in promoting beta-catenin degradation.
- Investigated the dependence of this degradation on GSK-3beta phosphorylation and intact APC protein.
Main Results:
- The chimeric F-box fusion proteins effectively induced degradation of cytoplasmic beta-catenin.
- Beta-catenin degradation was achieved independently of GSK-3beta-mediated phosphorylation.
- Degradation of beta-catenin did not require the presence of intact Adenomatous polyposis coli (APC) protein.
Conclusions:
- Engineered chimeric F-box proteins offer a novel mechanism for targeted beta-catenin degradation.
- This approach provides a potential therapeutic strategy for cancers with dysregulated Wnt signaling, irrespective of APC status.
- The findings open new avenues for developing treatments for malignancies associated with beta-catenin accumulation.
Related Concept Videos
Catenins
Catenins in Cell Junctions
Catenins bind to cell adhesion molecules such as cadherins and link them to different cytoskeletal proteins depending on the type of cell junction. At the adherens...
Canonical Wnt Signaling Pathway
Protein Complexes with Interchangeable Parts
The SCF ubiquitin ligase is a protein complex of five individual proteins. This complex attaches ubiquitin to other target proteins to mark them for degradation. In order to...
Anaphase Promoting Complex
Regulated Protein Degradation
Protein degradation plays two important roles in the cells. It helps to protect cells from misfolded or damaged proteins before they lead to a...
Non-Canonical Wnt Signaling Pathways

